Substituted Pyridazin-3(2H)-ones as Highly Potent and Biased Formyl Peptide Receptor Agonists

被引:19
作者
Deora, Girdhar Singh [2 ]
Qin, Cheng Xue [3 ,4 ]
Vecchio, Elizabeth A. [3 ]
Debono, Aaron J. [2 ]
Priebbenow, Daniel L. [2 ]
Brady, Ryan M. [2 ]
Beveridge, Julia [2 ]
Teguh, Silvia C. [2 ]
Minh Deo [3 ]
May, Lauren T. [5 ]
Krippner, Guy [3 ]
Ritchie, Rebecca H. [3 ,4 ,6 ]
Baell, Jonathan B. [1 ,2 ,7 ]
机构
[1] Nanjing Tech Univ, Sch Pharmaceut Sci, Nanjing 211816, Jiangsu, Peoples R China
[2] Monash Univ, Monash Inst Pharmaceut Sci, Med Chem, Parkville, Vic 3052, Australia
[3] Baker Heart & Diabet Inst, 7S Commercial Rd, Melbourne, Vic 3004, Australia
[4] Univ Melbourne, Dept Pharmacol & Therapeut, Melbourne, Vic 3010, Australia
[5] Monash Univ, Monash Inst Pharmaceut Sci, Drug Discovery Biol, Parkville, Vic 3052, Australia
[6] Monash Univ, Dept Diabet, Cent Clin Sch, Melbourne, Vic 3004, Australia
[7] Monash Univ, ARC Ctr Fragment Based Design, Parkville, Vic 3052, Australia
基金
英国医学研究理事会; 澳大利亚国家健康与医学研究理事会;
关键词
FUNCTIONAL SELECTIVITY; REPERFUSION INJURY; RESOLUTION; TARGET;
D O I
10.1021/acs.jmedchem.8b01912
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Herein we describe the development of a focused series of functionalized pyridazin-3(2H)-one-based formyl peptide receptor (FPR) agonists that demonstrate high potency and biased agonism. The compounds described demonstrated biased activation of prosurvival signaling, ERK1/2 phosphorylation, through diminution of the detrimental FPR1/2-mediated intracellular calcium (Ca-i(2+)) mobilization. Compound 50 showed an EC50 of 0.083 mu M for phosphorylation of ERK1/2 and an approximate 20-fold bias away from Ca-i(2+) mobilization at the hFPR1.
引用
收藏
页码:5242 / 5248
页数:7
相关论文
共 21 条
[11]   Seven Transmembrane Receptors as Shapeshifting Proteins: The Impact of Allosteric Modulation and Functional Selectivity on New Drug Discovery [J].
Kenakin, Terry ;
Miller, Laurence J. .
PHARMACOLOGICAL REVIEWS, 2010, 62 (02) :265-304
[12]   Formyl Peptide Receptors in Cellular Differentiation and Inflammatory Diseases [J].
Lee, Ha Young ;
Lee, Mingyu ;
Bae, Yoe-Sik .
JOURNAL OF CELLULAR BIOCHEMISTRY, 2017, 118 (06) :1300-1307
[13]   Resolution Pharmacology: Opportunities for Therapeutic Innovation in Inflammation [J].
Perretti, Mauro ;
Leroy, Xavier ;
Bland, Elliot J. ;
Montero-Melendez, Trinidad .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2015, 36 (11) :737-755
[14]   Cardioprotective Actions of the Annexin-A1 N-Terminal Peptide, Ac2-26, Against Myocardial Infarction [J].
Qin, Cheng Xue ;
Rosli, Sarah ;
Deo, Minh ;
Cao, Nga ;
Walsh, Jesse ;
Tate, Mitchel ;
Alexander, Amy E. ;
Donner, Daniel ;
Horlock, Duncan ;
Li, Renming ;
Kiriazis, Helen ;
Lee, Man K. S. ;
Bourke, Jane E. ;
Yang, Yuan ;
Murphy, Andrew J. ;
Du, Xiao-Jun ;
Gao, Xiao Ming ;
Ritchie, Rebecca H. .
FRONTIERS IN PHARMACOLOGY, 2019, 10
[15]   Reply to 'Compound 17b and formyl peptide receptor biased agonism in relation to cardioprotective effects in ischaemia-reperfusion injury' [J].
Qin, Cheng Xue ;
May, Lauren T. ;
Sexton, Patrick M. ;
DeBono, Aaron J. ;
Baell, Jonathan B. ;
Christopoulos, Arthur ;
Ritchie, Rebecca H. .
NATURE COMMUNICATIONS, 2018, 9
[16]   Small-molecule-biased formyl peptide receptor agonist compound 17b protects against myocardial ischaemia-reperfusion injury in mice [J].
Qin, Cheng Xue ;
May, Lauren T. ;
Li, Renming ;
Cao, Nga ;
Rosli, Sarah ;
Minh Deo ;
Alexander, Amy E. ;
Horlock, Duncan ;
Bourke, Jane E. ;
Yang, Yuan H. ;
Stewart, Alastair G. ;
Kaye, David M. ;
Du, Xiao-Jun ;
Sexton, Patrick M. ;
Christopoulos, Arthur ;
Gao, Xiao-Ming ;
Ritchie, Rebecca H. .
NATURE COMMUNICATIONS, 2017, 8
[17]   Cardioprotective potential of annexin-A1 mimetics in myocardial infarction [J].
Qin, Chengxue ;
Yang, Yuan H. ;
May, Lauren ;
Gao, Xiaoming ;
Stewart, Alastair G. ;
Tu, Yan ;
Woodman, Owen L. ;
Ritchie, Rebecca H. .
PHARMACOLOGY & THERAPEUTICS, 2015, 148 :47-65
[18]   Recent developments in biased agonism [J].
Wisler, James W. ;
Xiao, Kunhong ;
Thomsen, Alex R. B. ;
Lefkowitz, Robert J. .
CURRENT OPINION IN CELL BIOLOGY, 2014, 27 :18-24
[19]   International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the Formyl Peptide Receptor (FPR) Family [J].
Ye, Richard D. ;
Boulay, Francois ;
Wang, Ji Ming ;
Dahlgren, Claes ;
Gerard, Craig ;
Parmentier, Marc ;
Serhan, Charles N. ;
Murphy, Philip M. .
PHARMACOLOGICAL REVIEWS, 2009, 61 (02) :119-161
[20]   Inhibition of extracellular signal-regulated kinase enhances ischemia/reoxygenation-induced apoptosis in cultured cardiac myocytes and exaggerates reperfusion injury in isolated perfused heart [J].
Yue, TL ;
Wang, CL ;
Gu, JL ;
Ma, XL ;
Kumar, S ;
Lee, JC ;
Feuerstein, GZ ;
Thomas, H ;
Maleeff, B ;
Ohlstein, EH .
CIRCULATION RESEARCH, 2000, 86 (06) :692-699